期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

酪氨酸激酶抑制剂治疗慢性髓性白血病不良反应的处理 被引量：4

下载PDF
导出
摘要 1前言 慢性髓性白血病（CML）伴有特异性Ph染色体/BCR-ABL整合基因，酷氨酸激酶抵制剂（TKI）针对CML致病基因BCR-ABL的治疗方式开启了肿瘤靶向治疗的新时代。
作者 刘兵城
机构地区 中国医学科学院血液病医院(血液学研究所)
出处 《中国处方药》 2013年第3期36-39,共4页 Journal of China Prescription Drug
关键词 慢性髓性白血病 酪氨酸激酶抑制剂 靶向治疗 不良反应 BCR-ABL 致病基因 PH染色体 治疗方式
分类号 R733.7 [医药卫生—肿瘤]
  • 相关文献

参考文献1

二级参考文献19

  • 1[1]Copland M,Jorgensen HG,Holyoake TL.Evolving molecular therapy for chronic myeloid leukaemia-are we on target?Hematology 2005; 10:349-359
  • 2[2]Schwetz BA.From the Food and Drug Administration.JAMA 2001; 286:35
  • 3[3]Demetri GD,von Mehren M,Blanke CD,Van den Abbeele AD,Eisenberg B,Roberts PJ,Heinrich MC,Tuveson DA,Singer S,Janicek M,Fletcher JA,Silverman SG,Silberman SL,Capdeville R,Kiese B,Peng B,Dimitrijevic S,Druker BJ,Corless C,Fletcher CD,Joensuu H.Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.N Engl J Med 2002; 347:472-480
  • 4[4]Cohen MH,Williams G,Johnson JR,Duan J,Gobburu J,Rahman A,Benson K,Leighton J,Kim SK,Wood R,Rothmann M,Chen G,U KM,Staten AM,Pazdur R.Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.Clin Cancer Res 2002; 8:935-942
  • 5[5]Talpaz M,Silver RT,Druker BJ,Goldman JM,Gambacorti-Passerini C,Guilhot F,Schiffer CA,Fischer T,Deininger MW,Lennard AL,Hochhaus A,Ottmann OG,Gratwohl A,Baccarani M,Stone R,Tura S,Mahon FX,Fernandes-Reese S,Gathmann I,Capdeville R,Kantarjian HM,Sawyers CL.Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia:results of a phase 2 study.Blood 2002; 99:1928-1937
  • 6[6]O'Brien SG,Guilhot F,Larson RA,Gathmann I,Baccarani M,Cervantes F,Cornelissen JJ,Fischer T,Hochhaus A,Hughes T,Lechner K,Nielsen JL,Rousselot P,Reiffers J,Saglio G,Shepherd J,Simonsson B,Gratwohl A,Goldman JM,Kantarjian H,Taylor K,Verhoef G,Bolton AE,Capdeville R,Druker BJ.Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.N Engl J Med 2003; 348:994-1004
  • 7[7]Cross TJ,Bagot C,Portmann B,Wendon J,Gillett D.Imatinib mesylate as a cause of acute liver failure.Am J Hematol 2006;81:189-192
  • 8[8]Lin NU,Sarantopoulos S,Stone JR,Galinsky I,Stone RM,Deangelo DJ,Soiffer RJ.Fatal hepatic necrosis following imatinib mesylate therapy.Blood 2003; 102:3455-3456
  • 9[9]Ayoub WS,Geller SA,Tran T,Martin P,Vierling JM,Poordad FF.Imatinib (Gleevec)-induced hepatotoxicity.J Clin Gastroenterol 2005; 39:75-77
  • 10[10]Ohyashiki K,Kuriyama Y,Nakajima A,Tauchi T,Ito Y,Miyazawa H,Kimura Y,Serizawa H,Ebihara Y.Imatinib mesylate-induced hepato-toxicity in chronic myeloid leukemia demonstrated focal necrosis resembling acute viral hepatitis.Leukemia 2002; 16:2160-2161

共引文献4

同被引文献26

  • 1吴洪斌,陆益,陆国椿.甲磺酸伊马替尼的不良反应及预防处理[J].中国新药杂志,2006,15(22):1923-1925. 被引量：18
  • 2弦間昭彦,史春虹.抗肿瘤药的药物性肺损害[J].日本医学介绍,2007,28(3):113-115. 被引量：7
  • 3Thambi P,Sausville EA.STI571(imatinib mesylate):the tale of a targeted therapy[J].Anticancer Drugs,2002,13:111-114.
  • 4Breccia M,Carmosino I,Russo E,et al.Early and tardive skin adverse events in chronic myeloid leukaemia patients treated with imatinib[J].Eur J Haematol,2005,74:121-123.
  • 5Gambacorti-Passerini C,Tornaghi L,Cavagnini F,et al.Gynaecomastia in men with chronic myeloid leukaemia after imatinib[J].Lancet,2003,361:1954-1956.
  • 6Ohnishi K, Sakai F, Kudoh S, et al. Twenty-seven cases ofdrug- induced interstitial lung disease associated with imatinibmesylate[J]. Leukemia, 2006, 20:1162-1164.
  • 7Yamasawa H, Sugiyama Y, Bando M, et al. Drug-induced pneumonitis associated with imatinibmesylate in a patient with idiopathic pulmonary fibrosis[J]. Respiration, 2008, 75(3): 350-354.
  • 8Shin H J,Chung J S,Cho G J.Imatinib interim therapy between chemotherapeutic cycles and in vivo purging prior to autologous stem cell transplantation,followed by maintenance therapy is a feasible treatment strategy in Philadelphia chromosome-positive acute lymphoblastic leukemia[J].Bone Marrow Transplant,2005,36(10):917-918.
  • 9王季石,卢英豪.难治性白血病治疗进展[J].实用医学杂志,2008,24(12):2023-2025. 被引量：2
  • 10刘辉,常乃柏,顾惜春,裴蕾,魏建平,范芸,李江涛,许小东,田园.自体造血干细胞移植治疗急性白血病的临床观察[J].临床血液学杂志,2009,22(1):24-26. 被引量：11

引证文献4

二级引证文献7

中国处方药
2013年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部